Patisiran
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 407 publications
Therapy of amyloidosis: stabilizers and silencers.
Journal: European heart journal supplements : journal of the European Society of Cardiology
Published: May 08, 2026
Extracellular vesicle-based delivery systems for nucleic acid therapeutics.
Journal: Molecular therapy. Nucleic acids
Published: April 06, 2026
Clinical Practice and Diagnostic Trends in Hereditary Transthyretin Amyloidosis: A 25-Year Observational Study.
Journal: Medicina (Kaunas, Lithuania)
Published: March 26, 2026
Clinical course after cardiac resynchronization therapy in transthyretin amyloid cardiomyopathy receiving disease-modifying therapy.
Journal: Heart and vessels
Published: February 26, 2026
Identification of a cell subpopulation with different response to lipid nanoparticles and effect of protein corona on uptake and transfection.
Journal: Materials today. Bio
Published: February 19, 2026
Diverse structures and shapes of lipid-based nanoparticles: Toward clinical translation.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 08, 2026
Efficacy of Suppression of Serum Transthyretin With Patisiran and Vutrisiran in Variant ATTR Amyloidosis: An Observational Crossover Study.
Journal: Circulation
Published: February 02, 2026
Multicenter cohort analysis of cardiac amyloidosis patients treated with heart transplant.
Journal: Revista espanola de cardiologia (English ed.)
Published: January 19, 2026
Pharmacological Interventions for Hereditary Transthyretin-Related Amyloidosis With Polyneuropathy: Systematic Review and Network Meta-Analysis.
Journal: European journal of neurology
Published: January 17, 2026
Impact of disease-modifying therapies on imaging parameters in cardiac amyloidosis: A systematic review and meta-analysis.
Journal: Current problems in cardiology
Published: January 07, 2026
Therapeutic siRNA: Mechanisms, challenges, strategies, and clinical translation.
Journal: Chinese medical journal
Published: December 29, 2025
Precision medicine with pioneering RNAi therapeutics in ATTR amyloidosis: from bench to bedside.
Journal: European journal of internal medicine
Published: December 20, 2025
Last Updated: 06/30/2026